» Articles » PMID: 37754118

Advancing Healthcare: Synergizing Biosensors and Machine Learning for Early Cancer Diagnosis

Overview
Specialty Biotechnology
Date 2023 Sep 27
PMID 37754118
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer is a fatal disease and a significant cause of millions of deaths. Traditional methods for cancer detection often have limitations in identifying the disease in its early stages, and they can be expensive and time-consuming. Since cancer typically lacks symptoms and is often only detected at advanced stages, it is crucial to use affordable technologies that can provide quick results at the point of care for early diagnosis. Biosensors that target specific biomarkers associated with different types of cancer offer an alternative diagnostic approach at the point of care. Recent advancements in manufacturing and design technologies have enabled the miniaturization and cost reduction of point-of-care devices, making them practical for diagnosing various cancer diseases. Furthermore, machine learning (ML) algorithms have been employed to analyze sensor data and extract valuable information through the use of statistical techniques. In this review paper, we provide details on how various machine learning algorithms contribute to the ongoing development of advanced data processing techniques for biosensors, which are continually emerging. We also provide information on the various technologies used in point-of-care cancer diagnostic biosensors, along with a comparison of the performance of different ML algorithms and sensing modalities in terms of classification accuracy.

Citing Articles

Graphene metasurfaces biosensor for COVID-19 detection in the infra-red regime.

Elsayed H, Wekalao J, Mehaney A, Alfassam H, Abukhadra M, Hajjiah A Sci Rep. 2025; 15(1):8573.

PMID: 40075176 PMC: 11903668. DOI: 10.1038/s41598-025-92991-w.


Recent Advances in SAW Sensors for Detection of Cancer Biomarkers.

Aleixandre M, Horrillo M Biosensors (Basel). 2025; 15(2).

PMID: 39996991 PMC: 11852368. DOI: 10.3390/bios15020088.


Artificial-Intelligence Bio-Inspired Peptide for Salivary Detection of SARS-CoV-2 in Electrochemical Biosensor Integrated with Machine Learning Algorithms.

Garcia-Junior M, Andrade B, Lima A, Soares I, Notario A, Bernardino S Biosensors (Basel). 2025; 15(2).

PMID: 39996977 PMC: 11853606. DOI: 10.3390/bios15020075.


Microfluidic Assays for CD4 T Lymphocyte Counting: A Review.

Meng Z, Raji H, Kokabi M, Zou D, Chan J, Liu Q Biosensors (Basel). 2025; 15(1).

PMID: 39852084 PMC: 11763704. DOI: 10.3390/bios15010033.


Advancements of paper-based sensors for antibiotic-resistant bacterial species identification.

Laliwala A, Pant A, Svechkarev D, Sadykov M, Mohs A NPJ Biosens. 2024; 1(1):17.

PMID: 39678719 PMC: 11645268. DOI: 10.1038/s44328-024-00016-9.


References
1.
Ahmad A, Sala F, Paie P, Candeo A, DAnnunzio S, Zippo A . On the robustness of machine learning algorithms toward microfluidic distortions for cell classification on-chip fluorescence microscopy. Lab Chip. 2022; 22(18):3453-3463. DOI: 10.1039/d2lc00482h. View

2.
Queralto N, Berliner A, Goldsmith B, Martino R, Rhodes P, Lim S . Detecting cancer by breath volatile organic compound analysis: a review of array-based sensors. J Breath Res. 2014; 8(2):027112. DOI: 10.1088/1752-7155/8/2/027112. View

3.
Liu C, Wang Z, Jia J, Liu Q, Su X . High-content video flow cytometry with digital cell filtering for label-free cell classification by machine learning. Cytometry A. 2022; 103(4):325-334. DOI: 10.1002/cyto.a.24701. View

4.
DOrazio M, Murdocca M, Mencattini A, Casti P, Filippi J, Antonelli G . Machine learning phenomics (MLP) combining deep learning with time-lapse-microscopy for monitoring colorectal adenocarcinoma cells gene expression and drug-response. Sci Rep. 2022; 12(1):8545. PMC: 9123013. DOI: 10.1038/s41598-022-12364-5. View

5.
Salahi A, Honrado C, Moore J, Adair S, Bauer T, Swami N . Supervised learning on impedance cytometry data for label-free biophysical distinction of pancreatic cancer cells versus their associated fibroblasts under gemcitabine treatment. Biosens Bioelectron. 2023; 231:115262. PMC: 10134450. DOI: 10.1016/j.bios.2023.115262. View